Global DNA hypomethylation is associated with NTD-affected pregnancy: A case-control study

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 88, Issue 7, 2010, Pages 575-581

  Chen, Xiaoli ^a   Guo, Jin ^a   Lei, Yunping ^b   Zou, Jizhen ^a   Lu, Xiaolin ^a   Bao, Yihua ^a   Wu, Lihua ^a   Wu, Jianxin ^a   Zheng, Xiaoying ^c   Shen, Yiping ^d   Wu, Bai Lin ^d   Zhang, Ting ^a  

^a CAPITAL INSTITUTE OF PEDIATRICS   (China)

^b FUDAN UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Case control study; China; Global DNA hypomethylation; MTHFR; Neural tube defects

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ANENCEPHALUS; ARTICLE; BRAIN TISSUE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CRANIORACHISCHISIS; DNA METHYLATION; ENCEPHALOCELE; FEMALE; FETUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN; SPINA BIFIDA; ADULT; CASE CONTROL STUDY; CHINA; GENETICS; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CHINA; COMPARATIVE GENOMIC HYBRIDIZATION; DNA METHYLATION; FEMALE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; QUESTIONNAIRES; RISK FACTORS;

EID: 77954755253     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20670     Document Type: Article

References (50)

1. Afman LA, Blom HJ, Drittij MJ, et al. 2005. Inhibition of transmethylation disturbs neurulation in chick embryos. Brain Res Dev Brain Res 158:59-65.
2. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485-1490.
3. Blom HJ, Shaw GM, den Heijer M, et al. 2006. Neural tube defects and folate: case far from closed. Nature Rev Neurosci 7:724-731.
4. Botto LD, Moore CA, Khoury MJ, Erickson JD. 1999. Neural-tube defects. N Engl J Med 34:1509-1519.
5. Botto LD, Yang Q. 2000. 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862-877
6. Cameron M, Moran P. 2009. Prenatal screening and diagnosis of neural tube defects. Prenat Diagn 29:402-411.
7. Cecconi F, Piacentini M, Fimia GM, et al. 2008. The involvement of cell death and survival in neural tube defects: a distinct role for apoptosis and autophagy? Cell Death Differ 15:1170-1177.
8. Christman JK, Sheikhnejad G, Dizik M, et al. 1993. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis 14:551-557. (Pubitemid 23149981)
9. Copp AJ, Green NDE, Murdoch JN. 2003. The genetic basis of mammalian neurulation. Nature Reviews Genetics 4:784-793.
10. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neuraltube defect by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835. (Pubitemid 23003073)
11. De Marco P, Merello E, Mascelli S, Capra V. 2006. Current perspectives on the genetic causes of neural tube defects. Neurogenetics 7:201-221.
12. Duthie SJ. 1999. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55:578-592.
13. Eden A, Gaudet F, Waghmare A, et al. 2003. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300:455.
14. Ehrlich M. 2002. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. J Nutr 132(8 Suppl):2424S-2429S.
15. Li E. 2002. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet. 3:662-673. (Pubitemid 34984255)
16. Feuchtbaum LB, Currier RJ, Riggle S, et al. 1999. Neural tube defect prevalence in California (1990-1994): eliciting patterns by type of defect and maternal race/ethnicity. Genet Test 3:265-272.
17. Finnell RH, Spiegelstein O, Wlodarczyk B, et al. 2002. DNA methylation in Folbp1 knockout mice supplemented with folic acid during gestation. J Nutrition 132:2457s-2461s.
18. Friso S, Choi SW, Girelli D, et al. 2002. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate statuses. Proc Natl Acad Sci 99:5606-5611.
19. Frosst P, Blom HJ, Milos R, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
20. Gos M, Szpecht-Potocka A. 2002a. Genetic basis of neural tube defects. I. Regulatory genes for the neurulation process. J Appl Genet 43:343-350. (Pubitemid 135705671)
21. Gos M Jr, Szpecht-Potocka A. 2002b. Genetic basis of neural tube defects. II. Genes correlated with folate and methionine metabolism. J Appl Genet 43:511-524. (Pubitemid 135705687)
22. Gu X, Lin L, Zheng X, et al. 2007. High prevalence of NTDs in Shanxi Province: a combined epidemiological approach. Birth Defects Res A Clin Mol Teratol 79:702-707.
23. Hark AT, Schoenherr CJ, Katz DJ, et al. 2000. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405:486-489.
24. Harris MJ, Juriloff DM. 2007. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol 79:187-210.
25. Hsiung DT, Marsit CJ, Houseman EA, et al. 2007. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 16:108-114.
26. Jirtle RL, Skinner MK. 2007. Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253-262.
27. Jones PL, Veenstra GJ, Wade PA, et al. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187-191. (Pubitemid 28248804)
28. Kibar Z, Capra V, Gros P. 2007a. Toward understanding the genetic basis of neural tube defects. Clin Genet 71:295-310. (Pubitemid 46680796)
29. Kibar Z, Torban E, McDearmid JR, et al. 2007b. Mutations in VANGL1 associated with neural-tube defects. N Engl J Med 356:1432-1437.
30. Lary JM, Edmonds LD. 1996. Prevalence of spina bifida at birth - United States, 1983-1990: a comparison of two surveillance systems. MMWR CDC Surveill Summ 45(ss-2):15-26.
31. Li Z, Ren A, Zhang L, et al. 2006. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Terato 76:237-240.
32. Mitchell LE. 2005. Epidemiology of neural tube defects. Am J Med Genet C Semin Med Genet 135C:88-94.
33. Moretti ME, Bar-Oz B, Fried S, et al. 2005. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and metaanalysis. Epidemiology 16:216-219. (Pubitemid 40314414)
34. Okano M, Bell DW, Haber DA, Li E. 1999. DNA methyltransferase Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247-257. (Pubitemid 29519904)
35. Pei L, Zhu H, Ren A, et al. 2005. Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population. Birth Defects Res A Clin Mol Teratol 73:430-433.
36. Piedrahita JA, Oetama B, Bennett GD, et al. 1999. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nature Genet 23:228-232. (Pubitemid 29455399)
37. Rasmussen SA, Chu SY, Kim SY, et al. 2008. Maternal obesity and risk of neural tube defects: a meta-analysis. Am J Obstet Gynecol 198:611-9.
38. Reik W, Dean W, Walter J. 2001. Epigenetic reprogramming in mammalian development. Science 293:1089-1093.
39. Seller MJ. 1995. Multi-site neural tube closure in humans and maternal folate supplementation. Am J Med Genet 58:222-224.
40. Shaw GM, Todoroff K, Velie EM, et al. 1998. Maternal illness, including fever, and medication use as risk factors for neural tube defects. Teratology 57:1-7.
41. Shen Y, Irons M, Miller DT, et al. 2007. Development of a focused oligonucleotide-array comparative genomic hybridization chip for clinical diagnosis of genomic imbalance. Clin Chem 53:2051-2059
42. Smithells RW, Sheppard S, Schorah CJ, et al. 1976. Vitamin deficiencies and neural tube defects. Arch Dis Child 51:944-950.
43. Smithells RW, Nevin NC, Seller MJ, et al. 1983. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1(8332):1027-1031.
44. Van den Veyver IB. 2002. Genetic effects of methylation diets. Annu Rev Nutr 22:255-282.
45. van der Put NMJ, van Straaten HWM, Trijbels FJM, et al. 2001. Folate, homocysteine and neural tube defects: an overview. Exp Biol Med 226:243-270.
46. Wald N, Sneddon J, Densem J, et al. 1991. MRC Vitamin study research group: Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 338(8760):131-137.
47. Wang X, Wang RH, Li W, et al. 2004. Genetic interactions between Brca1 and Gadd45a in centrosome duplication, genetic stability, and neural tube closure. J Biol Chem 279:29606-29614.
48. Wolff GL, Kodell RL, Moore SR, et al. 1998. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 12:949-957.
49. Xiao KZ. 1989. The epidemiology of neural tube defects in China. Chin J Med 69:189-191.
50. Zhang T, Xin R, Gu X, et al. 2008. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr 12:1-7.